AstraZeneca PLC (BCBA:AZN)

AstraZeneca Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	422,272,134	209,469,693	169,189,470	37,097,138	18,693,290	11,037,557
Market Cap Growth	85.54%	23.81%	356.07%	98.45%	69.36%	39.47%
Enterprise Value	456,569,718	235,248,695	189,832,629	42,224,844	21,515,860	12,599,748
Last Close Price	71325.00	38289.98	31648.64	11043.13	5630.01	3446.95
PE Ratio	32.78	28.88	35.14	63.70	1625.31	41.07
PS Ratio	5.30	3.76	4.57	4.72	4.87	4.93
PB Ratio	6.70	4.97	5.34	5.65	4.63	8.39
P/FCF Ratio	24.34	20.45	23.29	24.03	37.36	34.20
P/OCF Ratio	20.35	17.13	20.23	21.35	30.53	27.35
EV/Sales Ratio	5.49	4.22	5.13	5.38	5.60	5.63
EV/EBITDA Ratio	15.39	12.99	16.51	17.35	31.27	21.44
EV/EBIT Ratio	20.09	17.65	24.34	27.05	72.32	34.29
EV/FCF Ratio	26.32	22.96	26.14	27.35	43.01	39.04
Debt / Equity Ratio	0.71	0.75	0.76	0.84	0.85	1.45
Debt / EBITDA Ratio	1.57	1.70	2.04	2.23	4.81	3.15
Debt / FCF Ratio	2.58	3.07	3.30	3.57	6.85	5.92
Asset Turnover	0.53	0.53	0.46	0.44	0.44	0.42
Inventory Turnover	1.59	1.80	1.59	1.26	1.85	1.45
Quick Ratio	0.69	0.67	0.58	0.62	0.67	0.67
Current Ratio	0.88	0.93	0.82	0.86	1.16	0.96
Return on Equity (ROE)	21.67%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	9.06%	7.88%	6.10%	5.46%	2.10%	4.26%
Return on Invested Capital (ROIC)	18.54%	16.27%	13.35%	13.75%	6.00%	11.87%
Return on Capital Employed (ROCE)	19.80%	17.00%	13.70%	12.60%	3.50%	9.40%
Earnings Yield	3.05%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	4.11%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	1.12%	8.35%	7.41%	4.65%	5.24%	6.83%
Payout Ratio	52.89%	65.80%	75.25%	132.72%	3442.86%	111.77%
Buyback Yield / Dilution	0.08%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Shareholder Return	1.20%	8.28%	7.28%	-4.67%	-3.45%	5.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.